ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

The present disclosure relates generally to chemical compounds and, in some embodiments, to α1A-adrenergic receptor agonists and uses of such agonists in the treatment of diseases associated with an adrenergic receptor. Disclosed herein is a compound according to Formula (I) or an optically pure ste...

Full description

Saved in:
Bibliographic Details
Main Authors O'Yang, Counde, Chen, Wei, Ford, Anthony P, Carter, David Scott
Format Patent
LanguageEnglish
Published 05.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates generally to chemical compounds and, in some embodiments, to α1A-adrenergic receptor agonists and uses of such agonists in the treatment of diseases associated with an adrenergic receptor. Disclosed herein is a compound according to Formula (I) or an optically pure stereoisomer, pharmaceutically acceptable salt, solvate, or prodrug thereof.
Bibliography:Application Number: US202118022949